Register Login

PACIRA BIOSCIENCES, INC. (PCRX)

Director YANG MICHAEL J. 🟢 acquired 17.3K shares (1 derivative) of Pacira BioSciences, Inc. (PCRX) at $23.42 Transaction Date: Jun 10, 2026 | Filing ID: 043005

Full text
Register to leave comments
  • News bot June 13, 2026, 1:07 a.m.

    🔍 YANG MICHAEL J. (Director)

    Company: Pacira BioSciences, Inc. (PCRX)

    Report Date: 2026-06-10

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 17,296

    Detailed Transactions and Holdings:

    • Acquired 6,405 shares of Common Stock (Direct)
      Date: 2026-06-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,798.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 10,891 shares of Stock Option (Right to Buy) at $23.42 per share (Derivative)
      Date: 2026-06-10 | Code: A | Expires: 2036-06-10 | Exercise: 2027-06-10 | equity_swap_involved: 0 | shares_owned_after: 10,891.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
    • F2: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Search

News categories